David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
J. Jill
JILL
$299M
| $261K | ﹤0.01% |
13,364
-27,943
| -68% | -$669K |
|
|
VERV
3702
DELISTED
Verve Therapeutics
VERV
| $261K | ﹤0.01% |
57,104
+19,120
| +50% | +$128K |
|
3703
CALL
Antero Resources
AR
$11.7B
| $259K | ﹤0.01% |
+6,400
| New | +$245K |
|
3704
Upwork
UPWK
$1.07B
| $259K | ﹤0.01% |
19,832
-164,284
| -89% | -$2.5M |
|
3705
CALL
Bilibili
BILI
$6.91B
| $258K | ﹤0.01% |
13,500
-70,400
| -84% | -$1.35M |
|
3706
PLAYSTUDIOS Inc
MYPS
$60.3M
| $257K | ﹤0.01% |
202,731
-27,277
| -12% | -$44.4K |
|
3707
iShares MSCI Thailand ETF
THD
$356M
| $257K | ﹤0.01% |
+4,947
| New | +$277K |
|
|
HPAIW
3708
Helport AI Warrants
HPAIW
| $256K | ﹤0.01% |
847,500
| – | – |
|
3709
Paymentus
PAY
$5.03B
| $256K | ﹤0.01% |
9,800
-400
| -4% | -$11.8K |
|
3710
V2X
VVX
$2.43B
| $254K | ﹤0.01% |
5,180
-49,979
| -91% | -$2.45M |
|
3711
National Health Investors
NHI
$3.59B
| $254K | ﹤0.01% |
+3,437
| New | +$242K |
|
3712
Altimmune
ALT
$605M
| $253K | ﹤0.01% |
50,516
-409,317
| -89% | -$2.59M |
|
3713
First Trust Financials AlphaDEX Fund
FXO
$1.13B
| $251K | ﹤0.01% |
4,736
-15,157
| -76% | -$829K |
|
3714
WisdomTree US MidCap Fund
EZM
$952M
| $250K | ﹤0.01% |
4,191
| – | – |
|
3715
PUT
Intellia Therapeutics
NTLA
$1.76B
| $250K | ﹤0.01% |
35,100
-29,400
| -46% | -$297K |
|
3716
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$1.05B
| $249K | ﹤0.01% |
5,098
-100
| -2% | -$5.08K |
|
3717
Lennar Class B
LEN.B
$20.9B
| $248K | ﹤0.01% |
2,278
-11,008
| -83% | -$1.31M |
|
3718
iShares US Healthcare Providers ETF
IHF
$1.24B
| $247K | ﹤0.01% |
4,673
-1,300
| -22% | -$66.8K |
|
3719
PUT
Nice
NICE
$5.87B
| $247K | ﹤0.01% |
1,600
| – | – |
|
3720
Graphic Packaging
GPK
$3.39B
| $246K | ﹤0.01% |
9,494
+1,066
| +13% | +$28.5K |
|
3721
CALL
Biogen
BIIB
$32.2B
| $246K | ﹤0.01% |
1,800
-1,100
| -38% | -$157K |
|
3722
PUT
Dream Finders Homes
DFH
$1.34B
| $246K | ﹤0.01% |
+10,900
| New | +$255K |
|
|
RUMBW
3723
RUM Group Inc Warrant
RUMBW
$16.7M
| $245K | ﹤0.01% |
106,572
| – | – |
|
3724
iShares US Consumer Discretionary ETF
IYC
$1.22B
| $244K | ﹤0.01% |
+2,758
| New | +$263K |
|
3725
Bank First Corp
BFC
$1.71B
| $243K | ﹤0.01% |
+2,415
| New | +$245K |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.